USA Veterinary Diagnostics Market: By Product Type (Ultrasound Imaging Systems, Computed Tomography Imaging Systems, Radiography (X-RAY), Video Endoscopy Imaging Systems, Magnetic Resonance Imaging Systems, Other Imaging Systems, Test Instruments, Consumables, Software and Services) Animal Type (Companion Animals, Livestock) Technology (Lateral Flow Assays, ELISA Tests, Allergen-specific Immunodiagnostic Tests, Immunoassay Analyzers, Other Immunodiagnostic Products, Clinical Chemistry Analysis, Glucose Monitoring, Blood Gas & Electrolyte Analysis, Polymerase Chain Reaction (PCR) Tests and Country Forecast 2020-2031

USA Veterinary Diagnostics Market size was valued at US$ 4.0 billion in 2024 and is expected to reach US$ 7.6 billion by 2031, growing at a significant CAGR of 9.8% from 2025-2031. The report provides a detailed overview of the market and that can be segmented by product type, animal type, technology, disease type, and end user. by product type, the market has been segmented into Ultrasound Imaging Systems, Computed Tomography Imaging Systems, Radiography (X-RAY), Video Endoscopy Imaging Systems, Magnetic Resonance Imaging Systems, Other Imaging Systems, Test Instruments, Consumables, Software and Services. The ultrasound imaging systems segment is likely to be the largest and fastest-growing segment in terms of product type. Based on animal type, the market is segmented into Companion Animals, Livestock.  Among these, the companion animals segment is expected to have the fastest-growing market during the forecast period 2022-2028.

Based on technology, the USA veterinary diagnostics market is segmented into Lateral Flow Assays, ELISA Tests, Allergen-specific Immunodiagnostic Tests, Immunoassay Analyzers, Other Immunodiagnostic Products, Clinical Chemistry Analysis, Glucose Monitoring, Blood Gas & Electrolyte Analysis, Polymerase Chain Reaction (PCR) Tests, Microarrays, other Molecular Diagnostic Products, Hematology Cartridges, Hematology Analyzers, Urinalysis Clips & Cartridges/Panels, Urine Analyzers, Urine Test Strips, Others. Lateral flow assays are expected to dominate the market in the future. Based on disease type, the market has been segmented into Infectious Diseases, Non-Infectious Diseases, Hereditary, Congenital and Acquired Diseases, General Ailments, Structural and Functional Diseases, Others. Infectious Diseases, segment expected to grow at the highest CAGR over the forecast years. Based on the end-user, the market has been segregated into Laboratories, Veterinary Hospitals and Clinics, Point-Of-Care/In-House Testing, Research Institutes and Universities. The Laboratories segment is to dominate other segments in the market according to Precision Business Insights.

Key Development

In January 2021, Heska Corporation (US) acquired Lacuna Diagnostics (US), this acquisition strengthened the company's portfolio of point-of-care digital cytology technology and telemedicine services.